BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19910354)

  • 1. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.
    Frosch DL; Grande D; Tarn DM; Kravitz RL
    Am J Public Health; 2010 Jan; 100(1):24-32. PubMed ID: 19910354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-to-consumer advertising of prescription drugs.
    Frosch DL; Grande D
    LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.
    Sullivan HW; Campbell M
    J Health Commun; 2015; 20(12):1391-6. PubMed ID: 26120940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.
    Mintzes B; Morgan S; Wright JM
    PLoS One; 2009 May; 4(5):e5699. PubMed ID: 19479084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A history of drug advertising: the evolving roles of consumers and consumer protection.
    Donohue J
    Milbank Q; 2006; 84(4):659-99. PubMed ID: 17096638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea.
    Suh HS; Lee D; Kim SY; Chee DH; Kang HY
    Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumers' knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines.
    Hoek J; Maubach N
    N Z Med J; 2007 Feb; 120(1249):U2425. PubMed ID: 17308562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drug coupons: evolution and need for regulation in direct-to-consumer advertising.
    Mackey TK; Yagi N; Liang BA
    Res Social Adm Pharm; 2014; 10(3):588-94. PubMed ID: 24120330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study.
    Schulz PJ; Crosignani F; Petrocchi S
    J Med Internet Res; 2023 Jul; 25():e40616. PubMed ID: 37459159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems associated with direct-to-consumer advertising (DTCA) of restricted, implantable medical devices: should the current regulatory approach be changed?
    Patsner B
    Food Drug Law J; 2009; 64(1):1-41. PubMed ID: 19998571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Exposure to Direct-To-Consumer Prescription Drug Advertising (DTCA) and Patients' Belief Accessibility and Medication Adherence.
    Im H; Huh J
    Health Commun; 2019 Aug; 34(9):975-983. PubMed ID: 29521524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-consumer advertising of prescription medications: Do you see what the public sees?
    Hampl JS; Bramlett-Solomon S; Wharton CM
    J Am Diet Assoc; 2006 Dec; 106(12):1937-40, 1942-3, 1945-6. PubMed ID: 17126621
    [No Abstract]   [Full Text] [Related]  

  • 15. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mintzes B
    Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New DTCA Guidance--Enough to Empower Consumers?
    Robertson CT
    N Engl J Med; 2015 Sep; 373(12):1085-7. PubMed ID: 26287748
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
    DeLorme DE; Huh J; Reid LN
    Health Mark Q; 2009; 26(4):293-314. PubMed ID: 19916096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea.
    Yang YM; Lee JJ; Jeong E; Kim SY; Han MA; Choi EJ
    PLoS One; 2018; 13(7):e0201108. PubMed ID: 30040833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016.
    Liu J; Avery RJ; Kim JJ; Niederdeppe J
    J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumer's Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence.
    Ju I; Ohs JE; Park JS
    Health Commun; 2020 May; 35(6):696-706. PubMed ID: 30835557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.